However, the activation of the VEGF pathway by dihydroartemisinin, along with its regulation of the PI3K/AKT/mTOR/ULK1 pathway, facilitates autophagy and retards the progression of NAFLD (171). The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.